RespireRx Pharmaceuticals (RSPID) Stock Chart & Stock Price History $0.0007 0.00 (-53.33%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartBuy This Stock RespireRx Pharmaceuticals Stock Price Performance The RespireRx Pharmaceuticals (RSPID) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 22.22%, with a year-to-date return of -72.00%. In the past month, the stock has increased 16.67%, reflecting recent market activity. As of the latest close, RespireRx Pharmaceuticals traded at $0.00 with a market cap of $51 thousand and volume of 3,000 shares. Receive RSPID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-53.33%1 Month PerformanceN/A3 Month Performance-65.00%Year-To-Date Performance-72.00%1 Year Performance-22.22% RSPID Stock Chart for Tuesday, August, 5, 2025 RSPID Chart by TradingView RespireRx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$0.00$0.00$0.00$0.003,000 shs$51,000.0008/01/2025$0.00$0.00$0.00$0.003,000 shs$108,000.0007/31/2025$0.00$0.00$0.00$0.004,598 shs$108,000.0007/30/2025$0.00$0.00$0.00$0.004,598 shs$108,000.0007/29/2025$0.00$0.00$0.00$0.004,598 shs$108,000.0007/28/2025$0.00$0.00$0.00$0.004,598 shs$108,000.0007/25/2025$0.00$0.00$0.00$0.004,100 shs$83,000.0007/24/2025$0.00$0.00$0.00$0.004,100 shs$83,000.0007/23/2025$0.00$0.00$0.00$0.004,100 shs$83,000.0007/22/2025$0.00$0.00-23.33%$0.00$0.004,100 shs$83,000.00 Get the Latest News and Ratings for RSPID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$0.00$0.00$0.00$0.0012,000 shs$108,000.0007/18/2025$0.00$0.00$0.00$0.001.47 million shs$79,000.0007/17/2025$0.00$0.00$0.00$0.001.47 million shs$79,000.0007/16/2025$0.00$0.00$0.00$0.001.47 million shs$79,000.0007/15/2025$0.00$0.00$0.00$0.001.47 million shs$79,000.0007/14/2025$0.00$0.00$0.00$0.001.47 million shs$79,000.0007/11/2025$0.00$0.00+87.50%$0.00$0.00499,700 shs$108,000.0007/10/2025$0.00$0.00$0.00$0.005,000 shs$58,000.0007/09/2025$0.00$0.00$0.00$0.005,000 shs$58,000.0007/08/2025$0.00$0.00$0.00$0.005,000 shs$58,000.0007/07/2025$0.00$0.00$0.00$0.005,000 shs$58,000.00 Related Companies Kaleido Biosciences Stock Chart 180 Life Sciences Stock Chart 3SBio Stock Chart 60 Degrees Pharmaceuticals Stock Chart Abcam Stock Chart Agentix Stock Chart AIM ImmunoTech Stock Chart Algernon Pharmaceuticals Stock Chart ALK-Abelló A/S Stock Chart Alpha Tau Medical Stock Chart Receive RSPID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RespireRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:RSPID) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RespireRx Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RespireRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RSPID Stock Alerts